{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T08:00:52Z","timestamp":1776844852316,"version":"3.51.2"},"reference-count":101,"publisher":"Informa UK Limited","issue":"1","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Hematology"],"published-print":{"date-parts":[[2021,1,2]]},"DOI":"10.1080\/17474086.2021.1858406","type":"journal-article","created":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T20:42:39Z","timestamp":1606941759000},"page":"7-29","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":12,"title":["An evaluation of ferric derisomaltose as a treatment for anemia"],"prefix":"10.1080","volume":"14","author":[{"given":"Xenophon","family":"Kassianides","sequence":"first","affiliation":[{"name":"Hull University Teaching Hospitals NHS Trust and Hull York Medical School","place":["Hull, UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Bodington","sequence":"additional","affiliation":[{"name":"Hull University Teaching Hospitals NHS Trust and Hull York Medical School","place":["Hull, UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0996-9622","authenticated-orcid":false,"given":"Sunil","family":"Bhandari","sequence":"additional","affiliation":[{"name":"Hull University Teaching Hospitals NHS Trust and Hull York Medical School","place":["Hull, UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2020,12,14]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph11030082"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32154-2"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24820"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14043"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.2147\/IJNRD.S89704"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2014.10.007"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61381-0"},{"key":"e_1_3_4_10_1","article-title":"Pre-operative anaemia: prevalence, consequences and approaches to management","author":"Mu\u00f1oz M","year":"2015","unstructured":"Mu\u00f1oz M, G\u00f3mez-Ram\u00edrez S, Campos A, et al. Pre-operative anaemia: prevalence, consequences and approaches to management. Blood Transfus. 2015;13(3):370\u2013379.","journal-title":"Blood Transfus"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.arth.2020.01.012"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12887-018-0990-5"},{"key":"e_1_3_4_13_1","article-title":"Iron-dependent histone 3 lysine 9 demethylation controls B cell proliferation and humoral immune responses","author":"Jiang Y","year":"2019","unstructured":"Jiang Y, Li C, Wu Q, et al. Iron-dependent histone 3 lysine 9 demethylation controls B cell proliferation and humoral immune responses. Nat Commun. 2019;10(1):2935.","journal-title":"Nat Commun"},{"key":"e_1_3_4_14_1","unstructured":"NICE Guideline NG8. Chronic kidney disease: managing anemia. [Internet]. 2015 [cited 2020 Jul 7]. Available from: https:\/\/www.nice.org.uk\/guidance\/ng8"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-017-0688-1"},{"key":"e_1_3_4_16_1","article-title":"KDIGO clinical practice guideline for anemia in chronic kidney disease [Internet]","author":"KIDGO Work Group, Kidney Disease: Improving Global Outcomes (KDIGO) Anemia Work Group","year":"2012","unstructured":"KIDGO Work Group, Kidney Disease: Improving Global Outcomes (KDIGO) Anemia Work Group. KDIGO clinical practice guideline for anemia in chronic kidney disease [Internet]. Kidney Int Suppl. 2012; Available from: http:\/\/kdigo.org\/home\/guidelines\/anemia-in-ckd\/%5Cnhttp:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2157171615310777","journal-title":"Kidney Int Suppl"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jju009"},{"key":"e_1_3_4_18_1","unstructured":"Anaemia - iron deficiency | topics A to Z | CKS | NICE [Internet]. [cited 2020 Oct 13]. Available from: https:\/\/cks.nice.org.uk\/topics\/anaemia-iron-deficiency\/"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2019.08.052"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-019-02223-z"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0117383"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/MNH.0000000000000263"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.13517"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2011.03.016"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2015.06.006"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-125618"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00716.x"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gft524"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f4822"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S30015"},{"key":"e_1_3_4_31_1","first-page":"04.","article-title":"Pharmacokinetics of iron isomaltoside1000 in patients with stage 5 chronic kidney disease on dialysis therapy","author":"Gupta DR","year":"2013","unstructured":"Gupta DR, Larson DS, Thomsen LL, et al. Pharmacokinetics of iron isomaltoside1000 in patients with stage 5 chronic kidney disease on dialysis therapy. J Drug Metab Toxicol. 2013;04.","journal-title":"J Drug Metab Toxicol"},{"key":"e_1_3_4_32_1","unstructured":"Pharmacosmos UK Limited. SmPC: monofer 100mg\/ml solution for injection\/infusion [Internet]. EMC; 2020 [cited 2020 Oct 13]. Available from: https:\/\/www.medicines.org.uk\/EMC\/medicine\/23669\/SPC\/Monofer+100mg+ml+solution+for+injection+infusion\/#gref"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24633"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25564"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.22450"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.14521"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfv293"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfv096"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfaa011"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.5301\/JN.2011.6248"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.5414\/CN109474"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-020-01866-x"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-018-1159-z"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.5414\/CN108941"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.mib.0000235097.86360.04"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23354"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2013.335"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.3109\/00365521.2015.1031168"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1080\/00365521.2016.1196496"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/4585164"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1080\/00365521.2018.1498914"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1136\/flgastro-2020-101406"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1111\/vox.12477"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2018.1449205"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1111\/vox.12475"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-020-05509-2"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25094"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1729"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1080\/01635581.2018.1504090"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0908355"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu385"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.027497"},{"key":"e_1_3_4_63_1","first-page":"131","article-title":"Effects of administration of iron isomaltoside 1000 in patients with chronic heart failure","volume":"11","author":"Hildebrandt PR","year":"2010","unstructured":"Hildebrandt PR, Bruun NE, Nielsen OW, et al. Effects of administration of iron isomaltoside 1000 in patients with chronic heart failure. A Pilot Study. 2010;11:131\u2013137. Transfus Altern Transfus Med","journal-title":"A Pilot Study"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.038516"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1159\/000507872"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1111\/anae.13773"},{"issue":"3","key":"e_1_3_4_67_1","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/vox.12278","article-title":"Intravenous iron isomaltoside 1000 (Monofer) reduces postoperative anaemia in preoperatively non-anaemic patients undergoing elective or subacute coronary artery bypass graft, valve replacement or a combination thereof: a randomized double-blind placebo-controlled clinical trial (thePROTEC trial)","volume":"109","author":"Johansson PI","year":"2015","unstructured":"Johansson PI, Rasmussen AS, Thomsen LL. Intravenous iron isomaltoside 1000 (Monofer) reduces postoperative anaemia in preoperatively non-anaemic patients undergoing elective or subacute coronary artery bypass graft, valve replacement or a combination thereof: a randomized double-blind placebo-controlled clinical trial (thePROTEC trial). Vox Sang. 2015;109(3):257\u2013266.","journal-title":"Vox Sang"},{"key":"e_1_3_4_68_1","first-page":"506","article-title":"Intravenous iron supplementation with intra-articular administration of tranexamic acid reduces the rate of allogeneic transfusions after simultaneous bilateral total knee arthroplasty","volume":"15","author":"Won Suh D","year":"2017","unstructured":"Won Suh D, Han SB, Park JH, et al. Intravenous iron supplementation with intra-articular administration of tranexamic acid reduces the rate of allogeneic transfusions after simultaneous bilateral total knee arthroplasty. Blood Transfus. 2017;15:506\u2013511.","journal-title":"Blood Transfus"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(96)90463-1"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60689-8"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.1159\/000451069"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfu201"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.01090115"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2015.163"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1810742"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-019-3291-x"},{"key":"e_1_3_4_77_1","first-page":"35(Supple_3)","article-title":"So051Prospective open-label explorative randomised single centre comparative study to determine the effects of various intravenous iron preparations on haemoglobin, haemetenics, markers of kidney function, quality of Life and Safety","author":"Kassianides X","year":"2020","unstructured":"Kassianides X, Zeidan A, Bhandari S. So051Prospective open-label explorative randomised single centre comparative study to determine the effects of various intravenous iron preparations on haemoglobin, haemetenics, markers of kidney function, quality of Life and Safety. Nephrol Dial Transplant. 2020;35(Supple_3).","journal-title":"Nephrol Dial Transplant"},{"key":"e_1_3_4_78_1","first-page":"35(Supple_3)","article-title":"P0848Prospective open-label explorative randomised single-centre comparative study to determine the effects of various intravenous iron preparations on markers of oxidative stress and kidney injury in chronic kidney disease (iron-ckd)","author":"Kassianides X","year":"2020","unstructured":"Kassianides X, Zeidan A, Sturmey R, et al. P0848Prospective open-label explorative randomised single-centre comparative study to determine the effects of various intravenous iron preparations on markers of oxidative stress and kidney injury in chronic kidney disease (iron-ckd). Nephrol Dial Transplant. 2020;35(Supple_3).","journal-title":"Nephrol Dial Transplant"},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.3747\/pdi.2018.00125"},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2020.1709437"},{"key":"e_1_3_4_81_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.15837"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajo.12695"},{"key":"e_1_3_4_83_1","doi-asserted-by":"publisher","DOI":"10.1111\/apa.13681"},{"key":"e_1_3_4_84_1","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S243462"},{"key":"e_1_3_4_85_1","first-page":"E119","article-title":"Iron content in breast milk from mothers treated with a high single dose infusion of iron isomaltoside 1000 (Monofer)","volume":"131","author":"Holm C","year":"2015","unstructured":"Holm C, Thomsen LL, Norgaard A, et al. Iron content in breast milk from mothers treated with a high single dose infusion of iron isomaltoside 1000 (Monofer). Int J Gynecol Obs. 2015;131:E119.","journal-title":"Int J Gynecol Obs"},{"key":"e_1_3_4_86_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.1923"},{"key":"e_1_3_4_87_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15386"},{"key":"e_1_3_4_88_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13189"},{"key":"e_1_3_4_89_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0167146"},{"key":"e_1_3_4_90_1","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S17536"},{"key":"e_1_3_4_91_1","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S25882"},{"key":"e_1_3_4_92_1","doi-asserted-by":"publisher","DOI":"10.2147\/CEOR.S139525"},{"key":"e_1_3_4_93_1","doi-asserted-by":"publisher","DOI":"10.1080\/17425247.2017.1393412"},{"key":"e_1_3_4_94_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-018-0827-5"},{"key":"e_1_3_4_95_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2020.1745535"},{"key":"e_1_3_4_96_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-020-01241-0"},{"key":"e_1_3_4_97_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2019090972"},{"key":"e_1_3_4_98_1","doi-asserted-by":"publisher","DOI":"10.12788\/jcso.0232"},{"key":"e_1_3_4_99_1","doi-asserted-by":"publisher","DOI":"10.1111\/anae.14659"},{"key":"e_1_3_4_100_1","first-page":"199","article-title":"High-dose intravenous treatment in iron deficiency anaemia in inflammatory bowel disease: early efficacy and impact on quality of life","volume":"14","author":"Garc\u00eda-L\u00f3pez S","year":"2016","unstructured":"Garc\u00eda-L\u00f3pez S, Bocos JM, Gisbert JP, et al. High-dose intravenous treatment in iron deficiency anaemia in inflammatory bowel disease: early efficacy and impact on quality of life. Blood Transfus. 2016;14:199\u2013205.","journal-title":"Blood Transfus"},{"key":"e_1_3_4_101_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ackd.2019.05.002"},{"key":"e_1_3_4_102_1","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000314"},{"key":"e_1_3_4_103_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2016.12.011"}],"container-title":["Expert Review of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17474086.2021.1858406","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T15:59:35Z","timestamp":1770393575000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17474086.2021.1858406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,14]]},"references-count":101,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1,2]]}},"alternative-id":["10.1080\/17474086.2021.1858406"],"URL":"https:\/\/doi.org\/10.1080\/17474086.2021.1858406","relation":{},"ISSN":["1747-4086","1747-4094"],"issn-type":[{"value":"1747-4086","type":"print"},{"value":"1747-4094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,14]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierr20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierr20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-07-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}